“The revision to stable reflects our view of Elliot’s healthy volume and revenue growth in recent years that has led to an improved overall financial profile,” said Jennifer Soule, an S&P analyst.
The rating affirmation was based on the hospital’s strengths, including its improved financial performance and growth in unrestricted reserves. Those strengths are offset by Elliot’s elevated leverage for the rating level, according to S&P.
More articles on healthcare finance:
11 recent hospital outlook and rating actions
Sentara’s operating revenue gets boost from hospital acquisition
Erlanger fires 4 top administrators over ‘unacceptable fiscal management’
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
